Search - tctmd.com

Displaying 61 - 80 of 94

Sort: Relevancy | Date

News Daily News

MitraClip Appears Safe, Effective for Patients with Noncentral Regurgitatior

L.A. McKeown

September 20, 2013

News Daily News

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

June 07, 2013

News Daily News

Los Datos de un Registro Postcomercialización revelan que MitraClip es Seguro y Eficaz contra la RM

June 07, 2013

News Daily News

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

May 17, 2013

News Daily News

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

May 17, 2013

News Daily News

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

L.A. McKeown

April 05, 2013

News Daily News

La Comisurotomía Mitral Percutánea Revela un Éxito a Largo Plazo, aún con Reintervenciones

L.A. McKeown

April 05, 2013

News Daily News

Panel de cierre de la FDA vota a favor del MitraClip para pacientes con RM que no tienen otras opciones

March 25, 2013

News Daily News

Close FDA Panel Vote Favors MitraClip for MR Patients with No Other Options

March 25, 2013

News Industry News

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

March 20, 2013

News Industry News

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery

March 09, 2013

News Daily News

MitraClip Performs Well Even in Patients with Degenerative Regurgitation

L.A. McKeown

February 26, 2013

News Daily News

MitraClip Funciona Bien aún en Pacientes con Regurgitación Degenerativa

L.A. McKeown

February 26, 2013

Presentation TCT 2013

The EVEREST II Randomized Controlled Trial (RCT): Three Year Outcomes

Presenter: Ted Feldman, Elyse Foster, Mansoor Qureshi, Brian Whisenant, John Williams, Donald Glower, Laura Mauri

January 31, 2013

Presentation TCT 2013

Cost Effectiveness of the MitraClip® Compared with Mitral Valve Surgery: 12-month Results from the EVEREST II Randomized Controlled Trial

Presenter: Matthew Reynolds, Benjamin Galper, Patricia Apruzzese, Joshua Walczak, Laura Mauri, Ted Feldman, Donald Glower, David Cohen

January 31, 2013

News Conference News AHA 2012

RIME: Mitral Annuloplasty Plus CABG Improves Functional Capacity, Regurgitation

Jason Kahn

November 06, 2012

News Conference News TCT 2012

Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness

October 25, 2012

Presentation TCT 2012

Lessons from EVEREST II

Presenter: Ted Feldman

October 24, 2012

News Conference News ESC 2012

Registries Show Strides for Transcatheter Valve Treatments in Europe

Caitlin E. Cox

August 27, 2012

News Industry News

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

March 20, 2012

Advertisement

MitraClip Appears Safe, Effective for Patients with Noncentral Regurgitatior

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

Los Datos de un Registro Postcomercialización revelan que MitraClip es Seguro y Eficaz contra la RM

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

La Comisurotomía Mitral Percutánea Revela un Éxito a Largo Plazo, aún con Reintervenciones

Panel de cierre de la FDA vota a favor del MitraClip para pacientes con RM que no tienen otras opciones

Close FDA Panel Vote Favors MitraClip for MR Patients with No Other Options

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery

MitraClip Performs Well Even in Patients with Degenerative Regurgitation

MitraClip Funciona Bien aún en Pacientes con Regurgitación Degenerativa

The EVEREST II Randomized Controlled Trial (RCT): Three Year Outcomes

Cost Effectiveness of the MitraClip® Compared with Mitral Valve Surgery: 12-month Results from the EVEREST II Randomized Controlled Trial

RIME: Mitral Annuloplasty Plus CABG Improves Functional Capacity, Regurgitation

Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness

Lessons from EVEREST II

Registries Show Strides for Transcatheter Valve Treatments in Europe

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content